Login

Ownership

13F as of Q2 2026 · 21.2M shares outstanding

Who owns Forte Biosciences, Inc.?

By type of holder
Institutions 95.9% Everyone else 4.2%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Concentration Top 10 holders own 58.1%
Federated Hermes, Inc. 9.9% · Orbimed Advisors LLC 7.4%
Institutional ownership
95.9%
+32.2 pts vs last qtr
Institutional holders
85
+17 vs last qtr
Net shares bought
+6.8M
by institutions in Q2 2026
New / sold out
31 / 14
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Jupiter Topco LLC NEW +1.4M
  • BlackRock, Inc. +1.2M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Janus Henderson Group PLC SOLD OUT −1.2M
  • Morgan Stanley −455.3K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Forte Biosciences, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2017–FY2022
+19.0%
+3.54% a year
Each share's claim on the business
−16.0%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $20.5M
over 6 fiscal years
Diluted shares, split-adjusted
81.8K446.1K810.4K2017: 584.3K shares'172018: 802.4K shares'182019: 84.3K shares'192020: 294.4K shares'202021: 558.7K shares'212022: 695.3K shares'22
Buybacks Stock-based comp
$0$3.4M$6.9M2017 buybacks: $02017 stock comp: $4.5M'172018 buybacks: $02018 stock comp: $6.9M'182019 buybacks: $02019 stock comp: $36.0K'192020 buybacks: $02020 stock comp: $956.0K'202021 buybacks: $02021 stock comp: $4.2M'212022 buybacks: $02022 stock comp: $4.0M'22

How patient are the owners?

Institutional shares by how long they've been held
5+ years14% 3–5 years0% 1–3 years40% Under 1 year46%
Quarterly turnover
45.3%
of institutional shares changed hands
Top 10 managers, median time held
1.5 years

Super Investors

Investment managers reporting Forte Biosciences, Inc. on Form 13F
FH
Federated Hermes, Inc.
Shares
2.1M
% of company
9.94%
Change vs last qtr
+345.0K (+19.5%)
Held since
2025
OA
Orbimed Advisors LLC
Shares
1.6M
% of company
7.43%
Change vs last qtr
+380.8K (+31.8%)
Held since
2024

28 more super investors behind a free account

See every manager holding Forte Biosciences, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting Forte Biosciences, Inc. on Form N-PORT; together they hold 29.0% of the company
FH
Federated Hermes Equity Funds
Position value
$95.9M
% of company
5.90%
% of the fund
1.95%
As of
July 31, 2026
FH
Federated Hermes Equity Funds
Position value
$63.7M
% of company
3.92%
% of the fund
2.24%
As of
July 31, 2026

23 more funds behind a free account

See every fund holding Forte Biosciences, Inc. and how much of the fund the position is.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support